...
首页> 外文期刊>Australian and New Zealand Journal of Obstetrics and Gynecology >Urinary retention following laparoscopic gynaecological surgery with or without 4% icodextrin anti-adhesion solution
【24h】

Urinary retention following laparoscopic gynaecological surgery with or without 4% icodextrin anti-adhesion solution

机译:腹腔镜妇科手术后的尿retention留,有或没有4%的艾考糊精抗粘连溶液

获取原文
获取原文并翻译 | 示例
           

摘要

Background Urinary retention is a recognised complication of laparoscopic surgery. Previous work showed an association with 4% icodextrin solution and urinary retention. Aims To determine the incidence of urinary retention following laparoscopic gynaecological surgery with or without the use of 4% icodextrin. Methods A prospective observational study of 147 women undergoing laparoscopic gynaecological surgery for benign pathology. Women had their planned laparoscopic procedure and either received icodextrin solution or nothing as determined by their treating surgeon at the time of the operation. Results From May 2011 to February 2012, 147 women were approached to participate in the study; of whom, 124 women were included: 62 received icodextrin and 62 did not. The women in the non-icodextrin group were significantly older (P = 0.007) and had a higher BMI (P = 0.03) than those in the icodextrin group. Following surgery, 27/124 (21.8%) women had post-operative urinary retention. Icodextrin was associated with significantly more urinary retention (P = 0.017), but did not extend hospital admission significantly (P = 0.14). The administration of icodextrin was associated with resection of moderate- or severe-stage endometriosis involving multiple surgical sites, whereas women in the non-icodextrin group were more likely to be having a hysterectomy. Conclusions In this non-randomised study, there were significantly more women with post-operative urinary retention when icodextrin was used; however, this did not contribute to an extended hospital admission. While there may be confounding factors, women receiving icodextrin should be warned of the possibility of urinary retention post-operatively, but that this is unlikely to affect their stay in hospital.
机译:背景技术尿retention留是腹腔镜手术公认的并发症。先前的工作表明与4%的艾考糊精溶液和尿retention留有关。目的确定腹腔镜妇科手术后有无使用4%艾考糊精的尿retention留发生率。方法对147例因良性病理而行腹腔镜妇科手术的妇女进行前瞻性观察研究。妇女进行了计划的腹腔镜手术,并且在手术时未接受艾考糊精溶液治疗,或者接受治疗的外科医生决定什么都没有。结果从2011年5月至2012年2月,共有147名妇女参加了研究。其中包括124名妇女:62名接受艾考糊精,而62名则没有。非艾考糊精组的女性比艾考糊精组的女性年龄更大(P = 0.007),BMI(P = 0.03)更高。手术后,有27/124(21.8%)名妇女术后尿retention留。 Icodextrin与尿retention留显着相关(P = 0.017),但未显着延长住院时间(P = 0.14)。艾考糊精的使用与中度或重度子宫内膜异位症的切除有关,涉及多个手术部位,而非艾考糊精组的女性更可能接受子宫切除术。结论在这项非随机研究中,使用艾考糊精的女性术后尿retention留的比例明显增加。但是,这并不能延长住院时间。尽管可能存在混淆因素,但应警告接受艾考糊精的妇女术后有尿retention留的可能性,但这不大可能影响其住院时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号